Astma
Epidemiologia

Astma jest jedną z najczęstszych przewlekłych chorób układu oddechowego, dotykającą globalnie ponad 262 miliony osób, z roczną śmiertelnością około 455 000 przypadków. Częstość występowania astmy waha się od 1% do 18% w zależności od regionu, z wyższą zapadalnością w krajach rozwiniętych i wśród osób o niższym statusie ekonomicznym. W USA astma dotyka około 8,7% populacji, a w Kanadzie częstość wzrosła z 6,5% do 10,8% w ciągu dekady. Występują istotne różnice demograficzne: u dzieci astma jest częstsza u chłopców (7,0%) niż u dziewcząt (5,4%), natomiast u dorosłych częściej chorują kobiety (10,8%) niż mężczyźni (6,5%). Osoby rasy czarnej i rdzenni mieszkańcy Ameryki wykazują najwyższe wskaźniki zachorowań, a status społeczno-ekonomiczny jest silnie skorelowany z ciężkością przebiegu choroby. Otyłość znacząco zwiększa ryzyko astmy (49,5% wśród osób otyłych), a palenie tytoniu pogarsza przebieg choroby.

Epidemiologia astmy – wprowadzenie

Astma jest jedną z najczęstszych niezakaźnych chorób przewlekłych, dotykającą zarówno dzieci, jak i dorosłych na całym świecie. Stanowi poważny problem zdrowia publicznego ze względu na wysoką częstość występowania, zachorowalność oraz śmiertelność w ciężkich przypadkach12. Według danych Światowej Organizacji Zdrowia (WHO), w 2019 roku na astmę chorowało około 262 milionów osób na świecie, a choroba ta spowodowała około 455 000 zgonów3. Inne źródła wskazują, że liczba chorych na astmę na świecie przekracza 300 milionów, a nawet 340 milionów osób, a częstość występowania nadal rośnie, szczególnie w krajach o niskich i średnich dochodach45.

Heterogeniczna natura astmy sprawia, że dokładna ocena częstości występowania jest trudna6. Globalna Inicjatywa na rzecz Astmy (GINA) definiuje astmę jako „heterogenną chorobę, zwykle charakteryzującą się przewlekłym stanem zapalnym dróg oddechowych. Jest ona definiowana poprzez występowanie objawów ze strony układu oddechowego, takich jak świszczący oddech, duszność, ucisk w klatce piersiowej i kaszel, które zmieniają się w czasie i natężeniu, wraz ze zmiennym ograniczeniem przepływu powietrza podczas wydechu”7.

Globalne trendy epidemiologiczne w astmie

Globalna epidemia astmy obserwowana jest zarówno u dzieci, jak i dorosłych i nadal trwa, szczególnie w krajach o niskich i średnich dochodach, chociaż w niektórych krajach rozwiniętych nastąpiła stabilizacja wskaźników8. Częstość występowania astmy różni się znacznie między krajami, od 1% do 18%9. Astma jest częściej występującym schorzeniem w krajach rozwiniętych niż rozwijających się, a w ramach krajów rozwiniętych częściej dotyka osoby o niższym statusie ekonomicznym. Odwrotnie jest w krajach rozwijających się, gdzie astma częściej występuje wśród osób zamożniejszych10.

Wzrost częstości występowania astmy był równoległy do wzrostu innych chorób alergicznych, takich jak alergiczny nieżyt nosa i wyprysk11. Jednak od około 2010 roku obserwuje się stabilizację wskaźników w niektórych krajach o wysokich dochodach, podczas gdy w krajach o niskich i średnich dochodach wskaźniki nadal rosną12.

Różnice regionalne w częstości występowania astmy

Dane epidemiologiczne pokazują znaczne zróżnicowanie geograficzne w częstości występowania astmy13:

  • W Stanach Zjednoczonych astma dotyka około 8,7% populacji, co stanowi wzrost w porównaniu z wcześniejszymi dekadami1415
  • W Wielkiej Brytanii około 5,4 miliona osób cierpi na astmę, z częstością 1 na 12 dorosłych i 1 na 11 dzieci, co plasuje Wielką Brytanię wśród krajów o najwyższych wskaźnikach występowania astmy w Europie16
  • W Kanadzie częstość występowania astmy wzrosła z 6,5% w latach 2000-2001 do 10,8% w latach 2010-2011, z najwyższą częstością występowania w Ontario (12,1%) i najniższą w Nunavut (3,8%)17
  • W Ameryce Łacińskiej około 40 milionów osób żyje z astmą, a częstość występowania astmy u dzieci przekracza 15% w większości krajów tego regionu18
  • W Japonii częstość występowania astmy wzrosła z około 1% do 10% lub więcej u dzieci i do około 6-10% u dorosłych od lat 60. XX wieku19
  • W całej Azji częstość występowania astmy u dorosłych wynosi poniżej 5%, podczas gdy u osób starszych wskaźniki wahają się od 1,3% do 15,3%20

Demografia astmy w populacji

Częstość występowania astmy różni się w zależności od czynników demograficznych, takich jak wiek, płeć, rasa/pochodzenie etniczne oraz status społeczno-ekonomiczny21.

Różnice związane z płcią i wiekiem

Wzorce zachorowań na astmę różnią się między dziećmi a dorosłymi oraz między kobietami a mężczyznami22. Wśród dzieci, astma jest częstsza u chłopców (7,0%) niż u dziewcząt (5,4%). Jednak wśród dorosłych, kobiety (10,8%) częściej niż mężczyźni (6,5%) cierpią na astmę23. Globalnie, kobiety stanowią 57% z 235 milionów osób żyjących z astmą (około 136 milionów kobiet)24.

Co interesujące, częstość występowania astmy różni się w zależności od płci na przestrzeni życia. Chociaż astma jest częstsza i cięższa u chłopców wśród dzieci, wiele kobiet doświadcza znacznego pogorszenia objawów w okresie dojrzewania i po nim25. W badaniu wykorzystującym dane NHANES z lat 1999-2020, wśród osób z astmą 36,0% stanowili mężczyźni, a 64,0% kobiety (p<0,001). Grupą wiekową o najwyższej częstości występowania astmy były osoby w wieku 60 lat i starsze (34,0%)26.

Różnice rasowe i etniczne

Częstość występowania astmy różni się znacznie w zależności od rasy i pochodzenia etnicznego27:

  • Osoby rasy czarnej oraz rdzenni mieszkańcy Ameryki mają najwyższe wskaźniki występowania astmy w porównaniu z innymi rasami i grupami etnicznymi. W 2022 roku osoby rasy czarnej (10,3%) były o 44% bardziej narażone na astmę niż osoby rasy białej (8,4%)28
  • Wśród podgrup latynoskich, Portorykańczycy w kontynentalnych Stanach Zjednoczonych mają najwyższy wskaźnik występowania astmy spośród wszystkich grup rasowych lub etnicznych, wynoszący 14,0% w latach 2016-201829
  • W Stanach Zjednoczonych częstość występowania astmy jest najwyższa wśród Portorykańczyków, Latynosów, Afroamerykanów, Filipińczyków, Amerykanów irlandzkiego pochodzenia i rdzennych Hawajczyków, a najniższa wśród Meksykanów i Koreańczyków30

W badaniu NHANES, osoby rasy białej nie-latynoskie miały najwyższą częstość występowania astmy (46,4%), a następnie osoby rasy czarnej nie-latynoskie (26,0%) (p<0,001)31.

Status społeczno-ekonomiczny a astma

Status społeczno-ekonomiczny jest silnie związany z częstością występowania i ciężkością astmy32:

  • W 2022 roku częstość występowania astmy zmniejszała się wraz ze wzrostem dochodów rodziny, z najwyższymi wskaźnikami (11,3%) wśród osób o dochodach rodziny poniżej progu ubóstwa33
  • W Stanach Zjednoczonych, status społeczno-ekonomiczny jest powiązany z rasą, dlatego populacje czarnoskóre i latynoskie są bardziej narażone na astmę z powodu wyższej koncentracji w obszarach o niskich dochodach34
  • Ta sama tendencja obserwowana jest na całym świecie – niższy status społeczno-ekonomiczny wiąże się z większą ciężkością objawów astmy35
  • Reaktywność dróg oddechowych i objawy u dzieci o niskim statusie społeczno-ekonomicznym w Kanadzie są zazwyczaj wyższe niż w obszarach o wyższych dochodach36

Badanie NHANES wykazało również znaczący związek między wskaźnikiem masy ciała (BMI) a częstością występowania astmy (p<0,001), przy czym osoby otyłe wykazywały najwyższą częstość występowania astmy (49,5%). W przeciwieństwie do tego, osoby z niedowagą wykazywały najniższą częstość występowania (1,5%)37.

Nadzór epidemiologiczny nad astmą

Dane z nadzoru nad astmą obejmują gromadzenie i analizy danych dotyczących astmy zarówno na poziomie krajowym, jak i stanowym. Dane krajowe są dostępne na temat chorobowości astmy, wizyt w oddziałach ratunkowych, hospitalizacji z powodu astmy oraz śmiertelności z powodu astmy38.

Systemy nadzoru i źródła danych

Kluczowe źródła danych nadzoru nad astmą obejmują3940:

  • Narodowe Centrum Statystyk Zdrowia (NCHS) – dostarcza dane na temat częstości występowania astmy, ograniczeń aktywności, dni nieobecności w pracy lub szkole, stosowania leków ratunkowych i kontrolujących, edukacji w zakresie samodzielnego zarządzania astmą, wizyt lekarskich, wizyt w oddziałach ratunkowych, hospitalizacji z powodu astmy oraz zgonów z powodu astmy
  • Behavioral Risk Factor Surveillance System (BRFSS) – dostarcza dane o częstości występowania astmy u dorosłych i dzieci na poziomie stanowym
  • BRFSS Asthma Call-back Survey (ACBS) – zapewnia szczegółowe dane stanowe i lokalne dotyczące astmy
  • Badania z serii NHANES (National Health and Nutrition Examination Survey)
  • Dane szpitalne i z oddziałów ratunkowych – zapewniają informacje o wizytach i hospitalizacjach związanych z astmą
  • Rejestry zgonów – dostarczają dane o śmiertelności związanej z astmą

Władze stanowe i lokalne często wykorzystują te dane do opracowywania własnych systemów nadzoru. Na przykład, Connecticut Asthma Program (CAP) wykorzystuje dane z BRFSS, Connecticut Hospital Information Management Exchange (CHIME) oraz Connecticut Vital Records Registry do monitorowania astmy w stanie41.

Elektroniczne narzędzia nadzoru nad astmą

Elektroniczne karty medyczne (EMR) oferują możliwość optymalizacji diagnozy i nadzoru nad chorobami przewlekłymi, takimi jak astma, oraz wspierają inicjatywy poprawy jakości, które zwiększają przestrzeganie opieki zalecanej w wytycznych42. Ustalone narzędzia translacji wiedzy dla astmy, takie jak elektroniczne kwestionariusze, skomputeryzowane systemy wspomagania decyzji klinicznych (CDSS), sieci nadzoru nad chorobami przewlekłymi i rejestry astmy, okazały się skuteczne w poprawie jakości diagnozy i opieki w astmie43.

Przykłady systemów nadzoru elektronicznego nad astmą obejmują44:

  • Ontario Asthma Surveillance Information System (OASIS) – kanadyjski system nadzoru nad astmą, który został ustanowiony w 2003 roku w celu zapewnienia populacyjnego longitudinalnego systemu nadzoru nad astmą45
  • Systemy monitorowania jakości opieki nad astmą
  • Systemy nadzoru nad astmą związaną z pracą

Cyfrowy system nadzoru nad astmą może wspierać przestrzeganie najlepszych praktyk w zakresie diagnozy i nadzoru nad astmą poprzez zachęcanie do stosowania obiektywnych metod potwierdzania diagnozy astmy w elektronicznej dokumentacji medycznej46.

Innowacyjne podejścia do nadzoru nad astmą

Pojawiają się innowacyjne podejścia do nadzoru nad astmą, takie jak4748:

  • Pediatryczny System Nadzoru nad Astmą (PASS) – system wprowadzony w hrabstwie Dallas we współpracy z Parkland Health i Dallas County Health and Human Services, który dostarcza informacji o pediatrycznej astmie na poziomie społeczności
  • Indeks Wrażliwości na Astmę Pediatryczną – łączy dane zdrowotne i społeczne, aby przewidzieć prawdopodobieństwo wizyty na oddziale ratunkowym lub hospitalizacji związanej z astmą na poziomie społeczności w ciągu trzech miesięcy49
  • Analizy geoprzestrzenne – umożliwiają wizualizację zjawisk związanych z astmą, wykrywanie obszarów o podwyższonych wskaźnikach wizyt na oddziałach ratunkowych oraz potencjalnie powiązanych zagrożeń środowiskowych w społecznościach i wokół nich50

Takie podejścia mogą pomóc w identyfikacji społeczności o wysokim ryzyku astmy, lepszym zrozumieniu czynników środowiskowych i społecznych wpływających na astmę oraz w planowaniu bardziej ukierunkowanych interwencji51.

Epidemiologia ciężkiej astmy

Ciężka astma stanowi niewielką podgrupę osób, które mają nieproporcjonalnie wysokie obciążenie zdrowotne52. Istnieje znaczna zmienność w szacunkach dotyczących częstości występowania ciężkiej astmy53.

Odsetek osób z ciężką astmą wydaje się być niższy w przypadku astmy dziecięcej w porównaniu do astmy u dorosłych54. Aby zapewnić bardziej użyteczne ramy kliniczne i badawcze do badania ciężkiej astmy dziecięcej, Bush i wsp. zaproponowali termin „Problematyczna ciężka astma” (PSA) dla dzieci, które wymagają skierowania do specjalisty z powodu pozornie słabej odpowiedzi na maksymalne leczenie astmy55.

Czynniki ryzyka ciężkiej astmy i złego rokowania

Czynniki ryzyka związane z cięższym przebiegiem astmy obejmują5657:

  • Niski dochód – astma jest bardziej rozpowszechniona wśród osób o niższych dochodach gospodarstw domowych. Czynniki takie jak złe warunki mieszkaniowe, narażenie na zanieczyszczenia środowiska i ograniczony dostęp do opieki zdrowotnej mogą przyczyniać się do tej dysproporcji
  • Rasa/pochodzenie etniczne – częstość występowania astmy różni się w zależności od rasy i pochodzenia etnicznego, przy czym osoby rasy czarnej i wielorasowe oraz osoby pochodzenia portorykańskiego mają wyższe wskaźniki
  • Wiek i płeć – częstość występowania astmy jest wyższa wśród dzieci, a ataki astmy są bardziej rozpowszechnione wśród dzieci, kobiet i osób wielorasowych
  • Otyłość – osoby otyłe mają 1,74 razy większe prawdopodobieństwo wystąpienia astmy w porównaniu do osób z niedowagą
  • Palenie tytoniu – wyższy wskaźnik astmy u palaczy (51,2%) w porównaniu do osób niepalących (48,4%)

Duże znaczenie ma również środowisko, w tym zanieczyszczenie powietrza, które jest ważnym czynnikiem ryzyka astmy, powodującym nowe przypadki i pogarszającym istniejącą chorobę58.

Ekonomiczne aspekty astmy

Astma nakłada znaczne obciążenie ekonomiczne na osoby dotknięte chorobą, systemy opieki zdrowotnej i społeczeństwo jako całość59.

Według Fundacji Astmy i Alergii Ameryki (AAFA), astma jest uważana za jedną z najczęstszych i najdroższych chorób w Stanach Zjednoczonych. Raporty wskazują, że roczne koszty ekonomiczne leczenia astmy wynoszą około 82 miliardów dolarów, a koszty medyczne stanowią prawie 50,3 miliarda dolarów60.

W Kalifornii, koszty hospitalizacji z powodu astmy są ogromne – 763 miliony dolarów w 2005 roku. Ta liczba nie obejmuje kosztów wizyt na oddziałach ratunkowych, które są prekursorem przyjęć do szpitala z powodu astmy. Właściwe działania prewencyjne mogłyby zmniejszyć wiele z tych negatywnych skutków i kosztów61.

Wykorzystanie opieki zdrowotnej

Wykorzystanie opieki zdrowotnej związane z astmą jest znaczące62:

  • W Kalifornii każdego roku z powodu astmy notuje się prawie 500 zgonów, 36 000 hospitalizacji i 145 000 wizyt na oddziałach ratunkowych (które nie skutkują hospitalizacją)
  • W Stanach Zjednoczonych wskaźniki hospitalizacji pediatrycznych z powodu astmy spadły ze 165 do 130 na 100 000 populacji w latach 2000-2010, podczas gdy wskaźnik dla dorosłych pozostał na poziomie około 119 na 100 000 populacji63
  • W 2010 roku astma stanowiła ponad jedną czwartą wizyt na oddziałach ratunkowych w USA wśród dzieci w wieku poniżej 19 lat64

Dane nadzoru pokazują, że istnieje duże pole do poprawy w rutynowej opiece zdrowotnej dla osób z astmą. Połowa dorosłych z astmą nie miała rutynowej kontroli astmy w ciągu ostatniego roku, a tylko około jedna trzecia dorosłych i dzieci z astmą otrzymała plan zarządzania astmą65.

Dysproporcje w zachorowalności na astmę

W prawie wszystkich wskaźnikach obciążenia astmą występują duże dysproporcje ze względu na rasę/pochodzenie etniczne, dochód, wiek, płeć i lokalizację geograficzną66.

Dysproporcje rasowe i etniczne

Osoby rasy czarnej mają szczególnie nieproporcjonalne wskaźniki wizyt na oddziałach ratunkowych, hospitalizacji i śmiertelności67. Wskaźniki przyjęć do szpitala związanych z astmą w 2010 roku były ponad trzy razy wyższe wśród dzieci rasy czarnej i dwa razy wyższe wśród dorosłych rasy czarnej i Latynosów w porównaniu z osobami rasy białej, azjatyckiej i mieszkańcami wysp Pacyfiku68.

Dysproporcje ekonomiczne

Chociaż osoby o wszystkich dochodach mają podobną częstość występowania astmy, osoby o niższych dochodach mają bardziej nasilone objawy, wyższe wskaźniki hospitalizacji i częściej doświadczają powtarzających się hospitalizacji69.

Dysproporcje geograficzne

Badanie z NHIS i NVSS wykazało, że70:

  • Obecna częstość występowania astmy była wyższa w północno-wschodniej części USA niż na południu i zachodzie, szczególnie w małych obszarach MSA (Metropolitan Statistical Areas)
  • Częstość występowania była również wyższa w małych i średnich obszarach metropolitalnych niż w dużych centralnych obszarach metropolitalnych
  • Częstość występowania ataków astmy różniła się według kategorii MSA w czterech stanach
  • Częstość wizyt na oddziałach ratunkowych była wyższa na południu niż na północnym wschodzie i środkowym zachodzie oraz była również wyższa w dużych centralnych obszarach metropolitalnych niż w obszarach mikropolitalnych i nieperyferyjnych
  • Wskaźnik śmiertelności z powodu astmy był najwyższy w obszarach nie-MSA, w szczególności w obszarach nieperyferyjnych
  • Wskaźnik śmiertelności z powodu astmy był również wyższy w północno-wschodniej, środkowo-zachodniej i zachodniej części kraju niż na południu

Międzynarodowe inicjatywy nadzoru nad astmą

Astma jest uwzględniona w Globalnym Planie Działania WHO na rzecz Zapobiegania i Kontroli Chorób Niezakaźnych oraz w Agendzie Zrównoważonego Rozwoju ONZ do 2030 roku71.

Pakiet Podstawowych Interwencji w Chorobach Niezakaźnych WHO (PEN) został opracowany, aby pomóc w poprawie zarządzania chorobami niezakaźnymi w podstawowej opiece zdrowotnej w warunkach o ograniczonych zasobach. PEN obejmuje protokoły oceny, diagnozy i zarządzania przewlekłymi chorobami układu oddechowego (astmą i przewlekłą obturacyjną chorobą płuc) oraz moduły dotyczące poradnictwa w zakresie zdrowego stylu życia, w tym zaprzestania palenia tytoniu i samoopieki72.

Globalna Inicjatywa na rzecz Astmy (GINA) przedstawia globalną strategię zarządzania i zapobiegania astmie w swoich dokumentach strategicznych, które są dostępne bezpłatnie na stronie internetowej GINA. GINA współpracuje z pracownikami służby zdrowia, przedstawicielami pacjentów i urzędnikami zdrowia publicznego na całym świecie w celu zmniejszenia częstości występowania, zachorowalności i śmiertelności z powodu astmy. GINA podkreśla potrzebę zapewnienia osobom z astmą dostępu do leków wziewnych, które są niezbędne zarówno do kontrolowania choroby podstawowej, jak i leczenia ataków73.

Wyzwania w nadzorze nad astmą

Nadzór nad astmą stoi przed kilkoma wyzwaniami74:

  • Brak dokumentacji potwierdzającej diagnozę astmy – mniej niż połowa osób zdiagnozowanych z astmą ma potwierdzoną diagnozę poprzez użycie obiektywnych pomiarów czynności płuc w ciągu dwóch lat od pierwotnej diagnozy75
  • Wyzwania związane z tworzeniem ważnej definicji przypadku astmy w EMR – przy braku takiej dokumentacji
  • Ograniczenia źródeł danych, które mogą informować narzędzia transferu wiedzy

Istniejące narzędzia do astmy są ograniczone w zakresie i wiele z nich nie uwzględnia barier i wyzwań w podstawowej opiece zdrowotnej, gdzie większość diagnoz astmy jest dokonywana76.

W Stanach Zjednoczonych badanie burz związanych z astmą jest utrudnione przez rzadkie pomiary danych pyłkowych, z mniej niż 60 stacjami dostępnymi w całym kraju. Wyniki badań sugerują, że dodatkowe pomiary pyłków mogą pozwolić na dokładniejsze przewidywanie astmy związanej z burzami, a wcześniejsze prace sugerują, że potrzebna jest większa gęstość pomiarów pyłków77.

Wnioski z nadzoru epidemiologicznego nad astmą

Pomimo pewnej poprawy wyników astmy z czasem, dane z nadzoru wskazują, że dysproporcje w wskaźnikach astmy utrzymują się w zależności od cech demograficznych, poziomu ubóstwa i lokalizacji geograficznej78.

Dysproporcje w wynikach astmy i wykorzystaniu opieki zdrowotnej w populacjach wiejskich i miejskich zidentyfikowane w NHIS i NVSS mogą pomóc programom zdrowia publicznego w kierowaniu zasobów i interwencji w celu poprawy wyników astmy79.

Osoby, które są kobietami, mają niskie dochody, są otyłe i palą, mają największe prawdopodobieństwo zachorowania na astmę. Dlatego polityki zdrowia publicznego powinny priorytetowo traktować te czynniki ryzyka w swoich strategiach zapobiegawczych80.

Większość osób dorosłych z astmą ma łagodne objawy, ale około jedna na cztery ma objawy o nasileniu umiarkowanym lub ciężkim. Około jedna trzecia dzieci z astmą miała atak w ciągu ostatniego roku81.

Bardziej zachęcające jest to, że dane wskazują na spadek wskaźników najcięższych wyników – hospitalizacji i zgonów82. Jednak należy nadal pracować nad poprawą rutynowej opieki zdrowotnej dla osób z astmą, aby jeszcze bardziej zmniejszyć obciążenie tą chorobą.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 12.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    Asthma is a globally significant non-communicable disease with major public health consequences for both children and adults, including high morbidity, and mortality in severe cases. […] While asthma incidence and prevalence are higher in children, morbidity, and mortality are higher in adults. […] The global epidemic of asthma that has been observed in both children and adults is still continuing, especially in low to middle income countries, although it has subsided in some developed countries. […] While some important environmental determinants that trigger asthma are well-established, more work is needed to define the role of environmental exposures in the development of asthma in both children and adults. […] Therefore, there is an urgent need to further investigate the interrelationship between environmental and genetic determinants to identify high risk groups and key modifiable exposures.
  • #2
    https://www.who.int/news-room/fact-sheets/detail/asthma
    Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children. […] Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths. […] Most asthma-related deaths occur in low- and lower-middle-income countries, where under-diagnosis and under-treatment is a challenge. […] Asthma is often under-diagnosed and under-treated, particularly in low- and middle-income countries. […] Access to inhalers is a problem in many countries. In 2021, bronchodilators were available in public primary health care facilities in half of low- and low-middle income countries, and steroid inhalers available in one third. […] Asthma is included in the WHO Global Action Plan for the Prevention and Control of NCDs and the United Nations 2030 Agenda for Sustainable Development.
  • #3
    https://www.who.int/news-room/fact-sheets/detail/asthma
    Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children. […] Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths. […] Most asthma-related deaths occur in low- and lower-middle-income countries, where under-diagnosis and under-treatment is a challenge. […] Asthma is often under-diagnosed and under-treated, particularly in low- and middle-income countries. […] Access to inhalers is a problem in many countries. In 2021, bronchodilators were available in public primary health care facilities in half of low- and low-middle income countries, and steroid inhalers available in one third. […] Asthma is included in the WHO Global Action Plan for the Prevention and Control of NCDs and the United Nations 2030 Agenda for Sustainable Development.
  • #4 Azthena logo with the word Azthena
    https://www.news-medical.net/health/Asthma-Epidemiology.aspx
    Asthma is a chronic respiratory disease involving inflammation and narrowing of the airways that is one of the major non-communicable diseases worldwide. There are more than 300 million individuals that currently suffer from the disease and the prevalence continues to grow with each year, particularly in low and middle-income countries. […] Worldwide, it is estimated that approximately 334 million people currently suffer from asthma, and 250,000 deaths are attributed to the disease each year. The prevalence of the disease is continuing to grow, and the overall prevalence is estimated to increase by 100 million by 2025. […] In the United Kingdom, there are 5.4 million people that currently rely on treatment to manage symptoms of asthma, with 1 in 12 adults affected and 1 in 11 children. This places the UK among countries with the highest rates of prevalence of asthma in Europe. […] The prevalence of asthma in the United States is on the rise with 1 in 12 adults, approximately 25 million individuals countrywide, affected by the condition in 2009 (in comparison to 1 in 14 in 2001).
  • #5 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    Future initiatives in the development of KT eTools for asthma care should focus on strategies that assist healthcare providers in accurately diagnosing and documenting cases of asthma. […] A digital asthma surveillance system could support adherence to best-practice guidelines of asthma diagnosis and surveillance by prompting use of objective methods of confirmation to confirm an asthma diagnosis within the EMR. […] Globally, the number of people diagnosed with asthma is over 340 million and has continually increased over a 10-year period. […] A major contributor to the burden of asthma on individuals and the healthcare system is that gaps exist between the published guidelines for asthma diagnosis and actual strategies for diagnosis used in primary care. […] Although standards for asthma diagnosis are well established, less than half of individuals diagnosed with asthma have a confirmed diagnosis through the use of objective measurements of pulmonary function within two years of their original diagnosis.
  • #6 Epidemiology of asthma – UpToDate
    https://www.uptodate.com/contents/epidemiology-of-asthma
    Epidemiology of asthma […] Asthma is a common, noncommunicable disease of the lungs affecting both children and adults. It has a global impact on health care utilization, quality of life, and mortality. The heterogeneous nature of the disease makes accurate assessment of prevalence challenging. […] The definition of asthma and the identification of affected individuals for epidemiologic purposes and data on trends in asthma prevalence will be reviewed here. […] Essential to any study of prevalence are the definition of the disease being studied and the methods available to identify affected individuals. Given the absence of a definitive laboratory test or biomarker for the diagnosis of asthma, many definitions and methods of data collection have been used and reported in epidemiologic studies; herein we discuss the most common. […] The Global Initiative for Asthma (GINA) defines asthma as, „a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness, and cough that vary over time and in intensity, together with variable expiratory airflow limitation.” This clinical definition is not easily translated into a form that can be used in population studies. A standard operational definition of asthma that can be used in all types of epidemiologic studies is lacking. […] A definition of asthma that was developed for epidemiologic studies to identify individuals with clinically important asthma combined wheezing in the past 12 months with AHR. However, this approach has not proven feasible because of the need for equipment, trained personnel, and the time needed in performing BHR or reversibility testing.
  • #7 Epidemiology of asthma – UpToDate
    https://www.uptodate.com/contents/epidemiology-of-asthma
    Epidemiology of asthma […] Asthma is a common, noncommunicable disease of the lungs affecting both children and adults. It has a global impact on health care utilization, quality of life, and mortality. The heterogeneous nature of the disease makes accurate assessment of prevalence challenging. […] The definition of asthma and the identification of affected individuals for epidemiologic purposes and data on trends in asthma prevalence will be reviewed here. […] Essential to any study of prevalence are the definition of the disease being studied and the methods available to identify affected individuals. Given the absence of a definitive laboratory test or biomarker for the diagnosis of asthma, many definitions and methods of data collection have been used and reported in epidemiologic studies; herein we discuss the most common. […] The Global Initiative for Asthma (GINA) defines asthma as, „a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness, and cough that vary over time and in intensity, together with variable expiratory airflow limitation.” This clinical definition is not easily translated into a form that can be used in population studies. A standard operational definition of asthma that can be used in all types of epidemiologic studies is lacking. […] A definition of asthma that was developed for epidemiologic studies to identify individuals with clinically important asthma combined wheezing in the past 12 months with AHR. However, this approach has not proven feasible because of the need for equipment, trained personnel, and the time needed in performing BHR or reversibility testing.
  • #8 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    Asthma is a globally significant non-communicable disease with major public health consequences for both children and adults, including high morbidity, and mortality in severe cases. […] While asthma incidence and prevalence are higher in children, morbidity, and mortality are higher in adults. […] The global epidemic of asthma that has been observed in both children and adults is still continuing, especially in low to middle income countries, although it has subsided in some developed countries. […] While some important environmental determinants that trigger asthma are well-established, more work is needed to define the role of environmental exposures in the development of asthma in both children and adults. […] Therefore, there is an urgent need to further investigate the interrelationship between environmental and genetic determinants to identify high risk groups and key modifiable exposures.
  • #9 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    As of 2011, approximately 235 million people worldwide were affected by asthma, and roughly 250,000 people die per year from asthma-related causes. Low and middle income countries make up more than 80% of the mortality. Prevalences vary between countries from 1% to 18%. Asthma tends to be more prevalent in developed than in developing countries. Rates are lower in Asia, Eastern Europe, and Africa. Within developed countries it is more common among those who are economically disadvantaged, but in contrast in developing countries it is more common amongst the affluent. The reason for these differences is not well known. […] The prevalence of childhood asthma in the United States has increased since 1980, especially in younger children. Rates of asthma have increased significantly between the 1960s and 2008 with it being recognized as a major public health problem since the 1970s. Some 9% of US children had asthma in 2001, compared with just 3.6% in 1980. The World Health Organization (WHO) reports that some 10% of the Swiss population have asthma as of 2007, compared with 2% some 2530 years ago. In the United States the age-adjusted prevalence of asthma increased from 7.3 to 8.2 percent during the years 2001 through 2009.
  • #10 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    As of 2011, approximately 235 million people worldwide were affected by asthma, and roughly 250,000 people die per year from asthma-related causes. Low and middle income countries make up more than 80% of the mortality. Prevalences vary between countries from 1% to 18%. Asthma tends to be more prevalent in developed than in developing countries. Rates are lower in Asia, Eastern Europe, and Africa. Within developed countries it is more common among those who are economically disadvantaged, but in contrast in developing countries it is more common amongst the affluent. The reason for these differences is not well known. […] The prevalence of childhood asthma in the United States has increased since 1980, especially in younger children. Rates of asthma have increased significantly between the 1960s and 2008 with it being recognized as a major public health problem since the 1970s. Some 9% of US children had asthma in 2001, compared with just 3.6% in 1980. The World Health Organization (WHO) reports that some 10% of the Swiss population have asthma as of 2007, compared with 2% some 2530 years ago. In the United States the age-adjusted prevalence of asthma increased from 7.3 to 8.2 percent during the years 2001 through 2009.
  • #11 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    Patterns in asthma incidence and prevalence differ between children and adults. […] Interestingly, incidence and prevalence of asthma differs by sex across the lifespan. […] The current evidence suggests that asthma is a complex multifactorial disorder and its etiology is increasingly attributed to interactions between genetic susceptibility, host factors, and environmental exposures. […] It is now acknowledged that the prevalence of both childhood and adult asthma may have peaked in some areas, predominantly in high-income countries, whereas an increase may be continuing in low and mid-income countries. […] The increase in asthma prevalence has been paralleled by a similar increase in other allergies such allergic rhinitis and eczema. […] Severe asthma represents a small subgroup of individuals who have a disproportionately high health burden.
  • #12 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    Patterns in asthma incidence and prevalence differ between children and adults. […] Interestingly, incidence and prevalence of asthma differs by sex across the lifespan. […] The current evidence suggests that asthma is a complex multifactorial disorder and its etiology is increasingly attributed to interactions between genetic susceptibility, host factors, and environmental exposures. […] It is now acknowledged that the prevalence of both childhood and adult asthma may have peaked in some areas, predominantly in high-income countries, whereas an increase may be continuing in low and mid-income countries. […] The increase in asthma prevalence has been paralleled by a similar increase in other allergies such allergic rhinitis and eczema. […] Severe asthma represents a small subgroup of individuals who have a disproportionately high health burden.
  • #13 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    As of 2011, approximately 235 million people worldwide were affected by asthma, and roughly 250,000 people die per year from asthma-related causes. Low and middle income countries make up more than 80% of the mortality. Prevalences vary between countries from 1% to 18%. Asthma tends to be more prevalent in developed than in developing countries. Rates are lower in Asia, Eastern Europe, and Africa. Within developed countries it is more common among those who are economically disadvantaged, but in contrast in developing countries it is more common amongst the affluent. The reason for these differences is not well known. […] The prevalence of childhood asthma in the United States has increased since 1980, especially in younger children. Rates of asthma have increased significantly between the 1960s and 2008 with it being recognized as a major public health problem since the 1970s. Some 9% of US children had asthma in 2001, compared with just 3.6% in 1980. The World Health Organization (WHO) reports that some 10% of the Swiss population have asthma as of 2007, compared with 2% some 2530 years ago. In the United States the age-adjusted prevalence of asthma increased from 7.3 to 8.2 percent during the years 2001 through 2009.
  • #14 Asthma prevalence among United States population insights from NHANES data analysis | Scientific Reports
    https://www.nature.com/articles/s41598-024-58429-5
    Asthma is a prevalent respiratory condition that poses a substantial burden on public health in the United States. Understanding its prevalence and associated risk factors is vital for informed policymaking and public health interventions. This study aims to examine asthma prevalence and identify major risk factors in the U.S. population. Our study utilized NHANES data between 1999 and 2020 to investigate asthma prevalence and associated risk factors within the U.S. population. The study found that asthma affected 8.7% of the U.S. population. Gender emerged as a significant factor, with 36.0% of asthma patients being male and 64.0% female (p0.001). Individuals aged 60 and older having the highest asthma prevalence at 34.0%. Non-Hispanic whites had the highest prevalence at 46.4%, followed by non-hispanic blacks at 26.0%. In contrast, Mexican Americans and other hispanic individuals had lower rates, at 9.6% and 9.0%, respectively. Females were 1.76 times more likely to have asthma than males (p0.001). Obese individuals had a 1.74 times higher likelihood of current asthma compared to underweight individuals (p0.001). Notably, both Non-Hispanic Whites and Non-Hispanic Blacks showed higher odds of current asthma compared to Mexican Americans (with adjusted odds ratios of 2.084 and 2.096, respectively, p0.001). The research findings indicate that asthma is prevalent in 8.7% of the U.S. population. Our study highlights that individuals who are female, have low income, are obese, and smoke have the highest likelihood of being affected by asthma. Therefore, public health policies should prioritize addressing these risk factors in their preventive strategies.
  • #15 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Asthma affects approximately 7% of the population of the United States and causes approximately 4,210 deaths per year. In 2005, asthma affected more than 22 million people, including 6 million children, and accounted for nearly 500,000 hospitalizations that same year. In 2010, asthma accounted for more than one-quarter of admitted emergency department visits in the U.S. among children aged 19 years, and it was a frequent diagnosis among children aged 10-17 years. From 2000 through 2010, the rate of pediatric hospital stays for asthma declined from 165 to 130 per 100,000 population, respectively, whereas the rate for adults remained about 119 per 100,000 population. […] Asthma prevalence in the U.S. is higher than in most other countries in the world, but varies drastically between ethnic populations. Asthma prevalence is highest in Puerto Ricans, Latino, African Americans, Filipinos, Irish Americans, and Native Hawaiians, and lowest in Mexicans and Koreans. Rates of asthma-related hospital admissions in 2010 were more than three times higher among African American children and two times higher for African American and Latino adults compared with White and Asian and Pacific Islander people. Also, children who are born in low-income families have higher risk of asthma.
  • #16 Azthena logo with the word Azthena
    https://www.news-medical.net/health/Asthma-Epidemiology.aspx
    Asthma is a chronic respiratory disease involving inflammation and narrowing of the airways that is one of the major non-communicable diseases worldwide. There are more than 300 million individuals that currently suffer from the disease and the prevalence continues to grow with each year, particularly in low and middle-income countries. […] Worldwide, it is estimated that approximately 334 million people currently suffer from asthma, and 250,000 deaths are attributed to the disease each year. The prevalence of the disease is continuing to grow, and the overall prevalence is estimated to increase by 100 million by 2025. […] In the United Kingdom, there are 5.4 million people that currently rely on treatment to manage symptoms of asthma, with 1 in 12 adults affected and 1 in 11 children. This places the UK among countries with the highest rates of prevalence of asthma in Europe. […] The prevalence of asthma in the United States is on the rise with 1 in 12 adults, approximately 25 million individuals countrywide, affected by the condition in 2009 (in comparison to 1 in 14 in 2001).
  • #17 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Data depicts an increasing trend in asthma prevalence among Canada’s population. In 2000-2001 asthma prevalence was monitored at 6.5%; by 2010-2011 a 4.3% increase was shown, with asthma prevalence totaling 10.8% of Canada’s population. Furthermore, asthma prevalence varies among the provinces of Canada; the highest prevalence is Ontario at 12.1%, and the lowest is Nunavut at 3.8%. Though there is an overall decrease in the incidence of new asthma cases in Canada, prevalence is rising. This can be attributed to a decrease in case-specific mortality due to improved management and control of asthma and its symptoms. […] It is approximated that 40 million Latin Americans live with asthma. In some reports, urban residency within Latin America has been found to be associated with an increased prevalence of asthma. Childhood asthma prevalence was found to be higher than 15 percent in a majority of Latin American countries. Similarly, a study published relating to asthma prevalence in Havana, Cuba estimated that approximately 9 percent of children under the age of 15 are undiagnosed for asthma, possible due to lack of resources in the region.
  • #18 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Data depicts an increasing trend in asthma prevalence among Canada’s population. In 2000-2001 asthma prevalence was monitored at 6.5%; by 2010-2011 a 4.3% increase was shown, with asthma prevalence totaling 10.8% of Canada’s population. Furthermore, asthma prevalence varies among the provinces of Canada; the highest prevalence is Ontario at 12.1%, and the lowest is Nunavut at 3.8%. Though there is an overall decrease in the incidence of new asthma cases in Canada, prevalence is rising. This can be attributed to a decrease in case-specific mortality due to improved management and control of asthma and its symptoms. […] It is approximated that 40 million Latin Americans live with asthma. In some reports, urban residency within Latin America has been found to be associated with an increased prevalence of asthma. Childhood asthma prevalence was found to be higher than 15 percent in a majority of Latin American countries. Similarly, a study published relating to asthma prevalence in Havana, Cuba estimated that approximately 9 percent of children under the age of 15 are undiagnosed for asthma, possible due to lack of resources in the region.
  • #19 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    The prevalence of asthma in adults in Japan is rapidly increasing, however there is a significant difference for the children in Japan. The mean prevalence of asthma in Japan has increased from about 1% to 10% or higher in children and to about 6-10% in adults since the 1960s. There has been a 1.5 fold increase in the prevalence of asthma per decade in Japan from the 1960s. […] Data regarding the epidemiology of asthma in the continent of Asia as whole is scarce, particularly regarding adult populations. However, similarly to much of the rest of the globe, prevalence of childhood asthma appears to be rising. Systematic childhood studies, such as the International Study of Asthma and Allergies in Childhood (ISAAC), provide data regarding the epidemiology of asthma among Asia’s youth population. Asthma prevalence among Asia’s adult population is less clear in comparison due to the comparatively higher monitoring of younger populations. However, the data available points to a positive correlation between age and asthma prevalence. Findings indicate that the prevalence of asthma among the Asian adult population is less than 5%; while findings pertaining to elderly populations illustrate a rate somewhere between 1.3 and 15.3%.
  • #20 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    The prevalence of asthma in adults in Japan is rapidly increasing, however there is a significant difference for the children in Japan. The mean prevalence of asthma in Japan has increased from about 1% to 10% or higher in children and to about 6-10% in adults since the 1960s. There has been a 1.5 fold increase in the prevalence of asthma per decade in Japan from the 1960s. […] Data regarding the epidemiology of asthma in the continent of Asia as whole is scarce, particularly regarding adult populations. However, similarly to much of the rest of the globe, prevalence of childhood asthma appears to be rising. Systematic childhood studies, such as the International Study of Asthma and Allergies in Childhood (ISAAC), provide data regarding the epidemiology of asthma among Asia’s youth population. Asthma prevalence among Asia’s adult population is less clear in comparison due to the comparatively higher monitoring of younger populations. However, the data available points to a positive correlation between age and asthma prevalence. Findings indicate that the prevalence of asthma among the Asian adult population is less than 5%; while findings pertaining to elderly populations illustrate a rate somewhere between 1.3 and 15.3%.
  • #21 Asthma Trends Brief: Current Asthma Demographics | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/current-demographics
    Current asthma rates are not the same across demographic groups. This page describes current asthma rates, defined as those who have ever been diagnosed with asthma by a healthcare professional and report still having asthma, by the following demographics: sex and age, race/ethnicity, Hispanic subgroups, family income, health insurance coverage, and state. […] Among children, current asthma is more common for males (7.0%) than females (5.4%). However, among adults, females (10.8%) are more likely than males (6.5%) to still have asthma. […] Black individuals and Indigenous Peoples have the highest current asthma rates compared to other races and ethnicities. In 2022, Black individuals (10.3%) were 44% more likely than white individuals (8.4%) to still have asthma. […] While asthma rates are relatively low for Latino individuals overall, rates vary significantly among subgroups. Puerto Ricans in the continental United States have the highest current asthma rate of any racial or ethnic group, at 14.0 percent over 2016 to 2018.
  • #22 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    Patterns in asthma incidence and prevalence differ between children and adults. […] Interestingly, incidence and prevalence of asthma differs by sex across the lifespan. […] The current evidence suggests that asthma is a complex multifactorial disorder and its etiology is increasingly attributed to interactions between genetic susceptibility, host factors, and environmental exposures. […] It is now acknowledged that the prevalence of both childhood and adult asthma may have peaked in some areas, predominantly in high-income countries, whereas an increase may be continuing in low and mid-income countries. […] The increase in asthma prevalence has been paralleled by a similar increase in other allergies such allergic rhinitis and eczema. […] Severe asthma represents a small subgroup of individuals who have a disproportionately high health burden.
  • #23 Asthma Trends Brief: Current Asthma Demographics | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/current-demographics
    Current asthma rates are not the same across demographic groups. This page describes current asthma rates, defined as those who have ever been diagnosed with asthma by a healthcare professional and report still having asthma, by the following demographics: sex and age, race/ethnicity, Hispanic subgroups, family income, health insurance coverage, and state. […] Among children, current asthma is more common for males (7.0%) than females (5.4%). However, among adults, females (10.8%) are more likely than males (6.5%) to still have asthma. […] Black individuals and Indigenous Peoples have the highest current asthma rates compared to other races and ethnicities. In 2022, Black individuals (10.3%) were 44% more likely than white individuals (8.4%) to still have asthma. […] While asthma rates are relatively low for Latino individuals overall, rates vary significantly among subgroups. Puerto Ricans in the continental United States have the highest current asthma rate of any racial or ethnic group, at 14.0 percent over 2016 to 2018.
  • #24 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Globally, there are 136 million women with asthma, 57% of the 235 million people living with asthma. In addition to being more common among women, women experience more severe symptoms and are more likely to die from asthma. The severity and frequency of asthma complications is related to both gender and age. Although asthma is more prevalent and more severe in boys among children, many women experience a significant worsening of symptoms around and after puberty.
  • #25 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Globally, there are 136 million women with asthma, 57% of the 235 million people living with asthma. In addition to being more common among women, women experience more severe symptoms and are more likely to die from asthma. The severity and frequency of asthma complications is related to both gender and age. Although asthma is more prevalent and more severe in boys among children, many women experience a significant worsening of symptoms around and after puberty.
  • #26 Asthma prevalence among United States population insights from NHANES data analysis | Scientific Reports
    https://www.nature.com/articles/s41598-024-58429-5
    The overall asthma prevalence percentage among the U.S. population was 8.7%. Among those with asthma, 36.0% were males, and 64.0% were females (p0.001). The age group with the highest asthma prevalence was individuals aged 60 years and older, at 34.0%, while participants aged 2029 showed the lowest percentage (p0.001). Non-Hispanic Whites had the highest asthma prevalence at 46.4%, followed by non-Hispanic Blacks at 26.0% (p0.001). Furthermore, an observed association of significance (p0.001) between body mass index (BMI) and the prevalence of asthma was found to be such that obese individuals exhibited the highest prevalence of asthma at 49.5%. In contrast, underweight individuals displayed the lowest prevalence (1.5%). Smoking and asthma were significantly associated (p0.001), with a higher rate of asthma in smokers (51.2%) compared to non-smokers (48.4%).
  • #27 Asthma Trends Brief: Current Asthma Demographics | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/current-demographics
    Current asthma rates are not the same across demographic groups. This page describes current asthma rates, defined as those who have ever been diagnosed with asthma by a healthcare professional and report still having asthma, by the following demographics: sex and age, race/ethnicity, Hispanic subgroups, family income, health insurance coverage, and state. […] Among children, current asthma is more common for males (7.0%) than females (5.4%). However, among adults, females (10.8%) are more likely than males (6.5%) to still have asthma. […] Black individuals and Indigenous Peoples have the highest current asthma rates compared to other races and ethnicities. In 2022, Black individuals (10.3%) were 44% more likely than white individuals (8.4%) to still have asthma. […] While asthma rates are relatively low for Latino individuals overall, rates vary significantly among subgroups. Puerto Ricans in the continental United States have the highest current asthma rate of any racial or ethnic group, at 14.0 percent over 2016 to 2018.
  • #28 Asthma Trends Brief: Current Asthma Demographics | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/current-demographics
    Current asthma rates are not the same across demographic groups. This page describes current asthma rates, defined as those who have ever been diagnosed with asthma by a healthcare professional and report still having asthma, by the following demographics: sex and age, race/ethnicity, Hispanic subgroups, family income, health insurance coverage, and state. […] Among children, current asthma is more common for males (7.0%) than females (5.4%). However, among adults, females (10.8%) are more likely than males (6.5%) to still have asthma. […] Black individuals and Indigenous Peoples have the highest current asthma rates compared to other races and ethnicities. In 2022, Black individuals (10.3%) were 44% more likely than white individuals (8.4%) to still have asthma. […] While asthma rates are relatively low for Latino individuals overall, rates vary significantly among subgroups. Puerto Ricans in the continental United States have the highest current asthma rate of any racial or ethnic group, at 14.0 percent over 2016 to 2018.
  • #29 Asthma Trends Brief: Current Asthma Demographics | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/current-demographics
    Current asthma rates are not the same across demographic groups. This page describes current asthma rates, defined as those who have ever been diagnosed with asthma by a healthcare professional and report still having asthma, by the following demographics: sex and age, race/ethnicity, Hispanic subgroups, family income, health insurance coverage, and state. […] Among children, current asthma is more common for males (7.0%) than females (5.4%). However, among adults, females (10.8%) are more likely than males (6.5%) to still have asthma. […] Black individuals and Indigenous Peoples have the highest current asthma rates compared to other races and ethnicities. In 2022, Black individuals (10.3%) were 44% more likely than white individuals (8.4%) to still have asthma. […] While asthma rates are relatively low for Latino individuals overall, rates vary significantly among subgroups. Puerto Ricans in the continental United States have the highest current asthma rate of any racial or ethnic group, at 14.0 percent over 2016 to 2018.
  • #30 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Asthma affects approximately 7% of the population of the United States and causes approximately 4,210 deaths per year. In 2005, asthma affected more than 22 million people, including 6 million children, and accounted for nearly 500,000 hospitalizations that same year. In 2010, asthma accounted for more than one-quarter of admitted emergency department visits in the U.S. among children aged 19 years, and it was a frequent diagnosis among children aged 10-17 years. From 2000 through 2010, the rate of pediatric hospital stays for asthma declined from 165 to 130 per 100,000 population, respectively, whereas the rate for adults remained about 119 per 100,000 population. […] Asthma prevalence in the U.S. is higher than in most other countries in the world, but varies drastically between ethnic populations. Asthma prevalence is highest in Puerto Ricans, Latino, African Americans, Filipinos, Irish Americans, and Native Hawaiians, and lowest in Mexicans and Koreans. Rates of asthma-related hospital admissions in 2010 were more than three times higher among African American children and two times higher for African American and Latino adults compared with White and Asian and Pacific Islander people. Also, children who are born in low-income families have higher risk of asthma.
  • #31 Asthma prevalence among United States population insights from NHANES data analysis | Scientific Reports
    https://www.nature.com/articles/s41598-024-58429-5
    The overall asthma prevalence percentage among the U.S. population was 8.7%. Among those with asthma, 36.0% were males, and 64.0% were females (p0.001). The age group with the highest asthma prevalence was individuals aged 60 years and older, at 34.0%, while participants aged 2029 showed the lowest percentage (p0.001). Non-Hispanic Whites had the highest asthma prevalence at 46.4%, followed by non-Hispanic Blacks at 26.0% (p0.001). Furthermore, an observed association of significance (p0.001) between body mass index (BMI) and the prevalence of asthma was found to be such that obese individuals exhibited the highest prevalence of asthma at 49.5%. In contrast, underweight individuals displayed the lowest prevalence (1.5%). Smoking and asthma were significantly associated (p0.001), with a higher rate of asthma in smokers (51.2%) compared to non-smokers (48.4%).
  • #32 Asthma Trends Brief: Current Asthma Demographics | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/current-demographics
    In 2022, current asthma rates decreased as family income increased, with the highest rates (11.3%) among those with a family income below the poverty threshold. […] In 2022, current asthma rates among adults ages 18 to 65 were highest for those on Medicaid and lowest for those with no medical insurance. […] In 2022, current asthma rates among adults ranged from 7.9% in Texas to 13.3% in Rhode Island. […] Among the thirty-one states with 2022 data, current asthma rates among children ranged from 4.5% in Illinois to 10.2% in Massachusetts.
  • #33 Asthma Trends Brief: Current Asthma Demographics | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/asthma-trends-brief/current-demographics
    In 2022, current asthma rates decreased as family income increased, with the highest rates (11.3%) among those with a family income below the poverty threshold. […] In 2022, current asthma rates among adults ages 18 to 65 were highest for those on Medicaid and lowest for those with no medical insurance. […] In 2022, current asthma rates among adults ranged from 7.9% in Texas to 13.3% in Rhode Island. […] Among the thirty-one states with 2022 data, current asthma rates among children ranged from 4.5% in Illinois to 10.2% in Massachusetts.
  • #34 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    In a review of studies on the prevalence of asthma among migrant populations, those born in high-income countries were found to have higher rates of asthma than migrants. Second-generation migrants had a higher risk of asthma than first-generation migrants, and the prevalence of asthma increases with longer time of residence in the host country. This confirms the role of the environment in the development of asthma. […] Disparities in the prevalence of asthma have been shown between different socioeconomic statuses. In the United States, socioeconomic status is associated with race, due to population trends, Black and Hispanic populations are more likely to have asthma, due to higher concentrations in low-income areas. In other areas of the world, the same trend that lower socioeconomic status is related to higher severity of asthma symptoms. Airway reactivity and symptoms for children of low socioeconomic status in Canada tend to be higher than those of higher-income areas.
  • #35 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    In a review of studies on the prevalence of asthma among migrant populations, those born in high-income countries were found to have higher rates of asthma than migrants. Second-generation migrants had a higher risk of asthma than first-generation migrants, and the prevalence of asthma increases with longer time of residence in the host country. This confirms the role of the environment in the development of asthma. […] Disparities in the prevalence of asthma have been shown between different socioeconomic statuses. In the United States, socioeconomic status is associated with race, due to population trends, Black and Hispanic populations are more likely to have asthma, due to higher concentrations in low-income areas. In other areas of the world, the same trend that lower socioeconomic status is related to higher severity of asthma symptoms. Airway reactivity and symptoms for children of low socioeconomic status in Canada tend to be higher than those of higher-income areas.
  • #36 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    In a review of studies on the prevalence of asthma among migrant populations, those born in high-income countries were found to have higher rates of asthma than migrants. Second-generation migrants had a higher risk of asthma than first-generation migrants, and the prevalence of asthma increases with longer time of residence in the host country. This confirms the role of the environment in the development of asthma. […] Disparities in the prevalence of asthma have been shown between different socioeconomic statuses. In the United States, socioeconomic status is associated with race, due to population trends, Black and Hispanic populations are more likely to have asthma, due to higher concentrations in low-income areas. In other areas of the world, the same trend that lower socioeconomic status is related to higher severity of asthma symptoms. Airway reactivity and symptoms for children of low socioeconomic status in Canada tend to be higher than those of higher-income areas.
  • #37 Asthma prevalence among United States population insights from NHANES data analysis | Scientific Reports
    https://www.nature.com/articles/s41598-024-58429-5
    The overall asthma prevalence percentage among the U.S. population was 8.7%. Among those with asthma, 36.0% were males, and 64.0% were females (p0.001). The age group with the highest asthma prevalence was individuals aged 60 years and older, at 34.0%, while participants aged 2029 showed the lowest percentage (p0.001). Non-Hispanic Whites had the highest asthma prevalence at 46.4%, followed by non-Hispanic Blacks at 26.0% (p0.001). Furthermore, an observed association of significance (p0.001) between body mass index (BMI) and the prevalence of asthma was found to be such that obese individuals exhibited the highest prevalence of asthma at 49.5%. In contrast, underweight individuals displayed the lowest prevalence (1.5%). Smoking and asthma were significantly associated (p0.001), with a higher rate of asthma in smokers (51.2%) compared to non-smokers (48.4%).
  • #38 Asthma Surveillance Data | Asthma Data | CDC
    https://www.cdc.gov/asthma-data/about/index.html
    Asthma surveillance data includes collection and analyses of asthma data at both the national and the state level. National data is available on asthma morbidity, emergency department visits, hospitalizations due to asthma, and asthma mortality. […] National data is available on asthma prevalence, activity limitation, days of work or school lost, rescue and control medication use, asthma self-management education, physician visits, emergency department visits, hospitalizations due to asthma, and deaths due to asthma from National Center for Health Statistics (NCHS) surveys and the Vital Statistics System. Asthma surveillance data at the state level include adult and child asthma prevalence from the Behavioral Risk Factor Surveillance System (BRFSS) and in-depth state and local asthma data through implementation of the BRFSS Asthma Call-back Survey (ACBS).
  • #39 Asthma Surveillance Data | Asthma | CDC
    https://www.cdc.gov/asthma/national-surveillance-data/default.htm
    Asthma surveillance data includes collection of asthma data at both the national and the state level. National data is available on asthma prevalence, activity limitation, days of work or school lost, rescue and control medication use, asthma self-management education, physician visits, emergency department visits, hospitalizations due to asthma, and deaths due to asthma from National Center for Health Statistics (NCHS) surveys and the Vital Statistics System. […] Asthma surveillance data at the state level include adult and child asthma prevalence from the Behavioral Risk Factor Surveillance System (BRFSS) and in-depth state and local asthma data through implementation of the BRFSS Asthma Call-back Survey (ACBS). […] Current asthma prevalence data by Metropolitan Micropolitan Statistical Areas are available at BRFSS Prevalence Trends Data: Home | DPH | CDC County-level current asthma prevalence data [model-based] are available at PLACES: Local Data for Better Health | CDC.
  • #40 Asthma Surveillance
    https://portal.ct.gov/DPH/Health-Education-Management–Surveillance/Asthma/Asthma-Surveillance
    Statistics include prevalence rates tables for adult and children with current or lifetime asthma from the Behavioral Risk Factor Surveillance System (BRFSS); hospitalization and emergency department acute rates for adult and children from the Connecticut Hospital Information Management Exchange (CHIME) and Mortality rates based on the Connecticut Vital Records Registry data. […] Reports are comprehensive documents that gather information from different sources specifically produced for a better insight of the burden of asthma in Connecticut or produced after a statutorily mandate for descriptive purposes of asthma in Connecticut schools. […] Data Briefs Fact Sheets are targeted estimates on specific subjects, such as estimates of asthma prevalence among the youth based on the Connecticut Youth Tobacco Survey data; Hospital Healthcare Utilization across Selected Geographic Designations or the Asthma Fact Sheet for the five Largest Cities in Connecticut based on the Connecticut Hospital Information Management Exchange (CHIME) data. […] Maps are produced using geocodable data from the Connecticut Health Information Exchange and the Connecticut Asthma Program.
  • #41 Asthma Surveillance
    https://portal.ct.gov/DPH/Health-Education-Management–Surveillance/Asthma/Asthma-Surveillance
    Statistics include prevalence rates tables for adult and children with current or lifetime asthma from the Behavioral Risk Factor Surveillance System (BRFSS); hospitalization and emergency department acute rates for adult and children from the Connecticut Hospital Information Management Exchange (CHIME) and Mortality rates based on the Connecticut Vital Records Registry data. […] Reports are comprehensive documents that gather information from different sources specifically produced for a better insight of the burden of asthma in Connecticut or produced after a statutorily mandate for descriptive purposes of asthma in Connecticut schools. […] Data Briefs Fact Sheets are targeted estimates on specific subjects, such as estimates of asthma prevalence among the youth based on the Connecticut Youth Tobacco Survey data; Hospital Healthcare Utilization across Selected Geographic Designations or the Asthma Fact Sheet for the five Largest Cities in Connecticut based on the Connecticut Hospital Information Management Exchange (CHIME) data. […] Maps are produced using geocodable data from the Connecticut Health Information Exchange and the Connecticut Asthma Program.
  • #42 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    Viable knowledge translation (KT) strategies are increasingly sought to improve asthma diagnosis, particularly in primary care. […] Electronic medical records (EMRs) offer an opportunity to optimize the diagnosis and surveillance of chronic diseases such as asthma, and support quality improvement initiatives that increase adherence to guideline-recommended care. […] Established KT eTools for asthma such as electronic questionnaires, computerized clinical decision support systems (CDSS), chronic disease surveillance networks, and asthma registries have been effective in improving the quality of asthma diagnosis and care. […] Chronic disease surveillance systems, severe asthma registries, and workplace asthma surveillance systems have demonstrated success in monitoring asthma outcomes.
  • #43 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    Viable knowledge translation (KT) strategies are increasingly sought to improve asthma diagnosis, particularly in primary care. […] Electronic medical records (EMRs) offer an opportunity to optimize the diagnosis and surveillance of chronic diseases such as asthma, and support quality improvement initiatives that increase adherence to guideline-recommended care. […] Established KT eTools for asthma such as electronic questionnaires, computerized clinical decision support systems (CDSS), chronic disease surveillance networks, and asthma registries have been effective in improving the quality of asthma diagnosis and care. […] Chronic disease surveillance systems, severe asthma registries, and workplace asthma surveillance systems have demonstrated success in monitoring asthma outcomes.
  • #44 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    Chronic disease surveillance networks are a category of asthma KT eTool that exist at international, national, and regional levels. […] An example of a chronic disease surveillance network for asthma is the Ontario Asthma Surveillance Information System (OASIS). […] Quality of care monitoring systems for asthma are emerging as useful eTools for KT. […] There are several surveillance systems dedicated to work-related asthma (WRA). […] KT eTools for asthma diagnosis have demonstrated effectiveness as a tool for quality improvement. […] An excellent opportunity exists for asthma KT eTool development by leveraging EMRs to support evidence-based diagnosis, surveillance, and quality improvement. […] KT eTools for asthma surveillance present a unique opportunity to improve provider diagnosis of asthma by promoting adherence to best-practice guidelines.
  • #45 OASIS – The Ontario Asthma Surveillance Information System
    https://lab.research.sickkids.ca/oasis/
    The Ontario Asthma Surveillance Information System (OASIS) was established in 2003 to provide a population-based longitudinal surveillance system for asthma. It continues to provide measures of asthma-related morbidity, mortality, health services use, and provider practice patterns.
  • #46 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    Future initiatives in the development of KT eTools for asthma care should focus on strategies that assist healthcare providers in accurately diagnosing and documenting cases of asthma. […] A digital asthma surveillance system could support adherence to best-practice guidelines of asthma diagnosis and surveillance by prompting use of objective methods of confirmation to confirm an asthma diagnosis within the EMR. […] Globally, the number of people diagnosed with asthma is over 340 million and has continually increased over a 10-year period. […] A major contributor to the burden of asthma on individuals and the healthcare system is that gaps exist between the published guidelines for asthma diagnosis and actual strategies for diagnosis used in primary care. […] Although standards for asthma diagnosis are well established, less than half of individuals diagnosed with asthma have a confirmed diagnosis through the use of objective measurements of pulmonary function within two years of their original diagnosis.
  • #47 DCHHS | Asthma Control Program
    https://www.dallascounty.org/departments/dchhs/public-health/chronic-disease/asthma-control-overview.php
    Asthma is a chronic disease that affects your lungs. It is one of the most common long-term diseases of children and adults. Asthma causes wheezing, breathlessness, chest tightness, and coughing. […] In partnership with Parkland Health and Parkland Center for Clinical Innovation, DCHHS is making available a new Pediatric Asthma Surveillance System (PASS) to provide community-based pediatric asthma prevalence information in Dallas County. […] The Pediatric Asthma Surveillance System (PASS) is a community wide dashboard that provides holistic insights into Pediatric Asthma Vulnerability in Dallas County. PASS introduces a novel, validated Pediatric Asthma Vulnerability Index, which brings together health and social data insights to predict children’s vulnerability to poor asthma outcomes and identify areas of health disparities.
  • #48 Interactive dashboard shows Dallas County communities with high asthma rates
    https://www.parklandhealth.org/news-and-updates/interactive-dashboard-shows-dallas-county-communit-2039
    Interactive dashboard shows Dallas County communities with high asthma rates […] Parkland Health and Dallas County Health and Human Services (DCHHS) in collaboration with Parkland Center for Clinical Innovation (PCCI) have launched a new Pediatric Asthma Surveillance System (PASS) that describes community-level information regarding pediatric asthma risk factors in Dallas County. […] The overall goal of this surveillance system is to provide current and accurate data to stakeholders interested in planning, developing and deploying pediatric asthma interventions, programs and policy. […] The Pediatric Asthma Surveillance System provides valuable key insights into pediatric asthma vulnerability and the associated clinical, demographic, environmental and social/economic drivers. […] PASS includes a novel, validated Pediatric Asthma Vulnerability Index, that integrates health and social data insights to identify communities where children have higher vulnerability to poor asthma outcomes and highlight areas of health disparities. […] The Pass is also meant to support Parkland and DCHHS efforts to reduce poor health outcomes related to pediatric asthma and will be used to outreach and engage parents or caregivers to participate in Parkland’s pediatric asthma text notification.
  • #49 DCHHS | Asthma Control Program
    https://www.dallascounty.org/departments/dchhs/public-health/chronic-disease/asthma-control-overview.php
    The Pediatric Asthma Vulnerability Index (also referred to as Vulnerability Index) predicts the probability of a community-level asthma-related emergency department (ED) visit or hospitalization within three months, by incorporating the effect of ten community indicators such as socioeconomic conditions, demographic characteristics, medication use patterns, health services utilization and environmental conditions, on community-level asthma risk. […] The Vulnerability Index and all indicators are categorized as Very High, High, Moderate, Low, or Very Low Risk based on their impact on Pediatric Asthma Vulnerability in the community.
  • #50 Progress in pediatric asthma surveillance II: geospatial patterns of asthma in Alameda County, California – Kaiser Permanente Division of Research
    https://divisionofresearch.kaiserpermanente.org/publications/progress-in-pediatric-asthma-surveillance-ii-geospatial-patterns-of-asthma-in-alameda-county-california/
    INTRODUCTION: As with many diseases, the epidemic of asthma among children over the past few decades has been shaped by a social and environmental context that is becoming progressively more evident. […] High-poverty communities had higher rates of emergency department visits due to asthma than low-poverty communities but had lower rates for indicators of quality primary asthma care. […] Geospatial analysis enabled visualization of this phenomenon; it further detected areas with elevated emergency department visit rates and potentially related environmental hazards in and around communities of concern. […] Areas of the county not previously considered to be deeply burdened by asthma were identified as having high emergency department visit rates. […] The assembly and high-resolution geospatial analysis of health care use data contributed to a more detailed depiction of pediatric asthma disparities than was previously available to community members, public health professionals, and clinicians. […] Information generated using these techniques facilitated discussion among stakeholders of the environmental and social contexts of asthma and health disparities in general.
  • #51 Progress in pediatric asthma surveillance II: geospatial patterns of asthma in Alameda County, California – Kaiser Permanente Division of Research
    https://divisionofresearch.kaiserpermanente.org/publications/progress-in-pediatric-asthma-surveillance-ii-geospatial-patterns-of-asthma-in-alameda-county-california/
    INTRODUCTION: As with many diseases, the epidemic of asthma among children over the past few decades has been shaped by a social and environmental context that is becoming progressively more evident. […] High-poverty communities had higher rates of emergency department visits due to asthma than low-poverty communities but had lower rates for indicators of quality primary asthma care. […] Geospatial analysis enabled visualization of this phenomenon; it further detected areas with elevated emergency department visit rates and potentially related environmental hazards in and around communities of concern. […] Areas of the county not previously considered to be deeply burdened by asthma were identified as having high emergency department visit rates. […] The assembly and high-resolution geospatial analysis of health care use data contributed to a more detailed depiction of pediatric asthma disparities than was previously available to community members, public health professionals, and clinicians. […] Information generated using these techniques facilitated discussion among stakeholders of the environmental and social contexts of asthma and health disparities in general.
  • #52 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    Patterns in asthma incidence and prevalence differ between children and adults. […] Interestingly, incidence and prevalence of asthma differs by sex across the lifespan. […] The current evidence suggests that asthma is a complex multifactorial disorder and its etiology is increasingly attributed to interactions between genetic susceptibility, host factors, and environmental exposures. […] It is now acknowledged that the prevalence of both childhood and adult asthma may have peaked in some areas, predominantly in high-income countries, whereas an increase may be continuing in low and mid-income countries. […] The increase in asthma prevalence has been paralleled by a similar increase in other allergies such allergic rhinitis and eczema. […] Severe asthma represents a small subgroup of individuals who have a disproportionately high health burden.
  • #53 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    There is considerable variation in the prevalence estimates of severe asthma. […] The proportion of severe asthmatics appears lower in childhood asthma compared to adult asthma. […] To provide a more useful clinical and research framework for the investigation of severe childhood asthma, Bush et al. have proposed the term Problematic severe asthma (PSA) for children who require specialist referral because of the apparent poor response to maximum asthma treatment. […] Although there is considerable within-group heterogeneity in each of the above categories, and strict differentiation may be challenging and on occasion not possible, the concepts which distinguish PSA, DA, and STRA are useful in both a research and clinical context. […] Childhood asthma and adult onset asthma are known to share many of the same causes and triggers.
  • #54 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    There is considerable variation in the prevalence estimates of severe asthma. […] The proportion of severe asthmatics appears lower in childhood asthma compared to adult asthma. […] To provide a more useful clinical and research framework for the investigation of severe childhood asthma, Bush et al. have proposed the term Problematic severe asthma (PSA) for children who require specialist referral because of the apparent poor response to maximum asthma treatment. […] Although there is considerable within-group heterogeneity in each of the above categories, and strict differentiation may be challenging and on occasion not possible, the concepts which distinguish PSA, DA, and STRA are useful in both a research and clinical context. […] Childhood asthma and adult onset asthma are known to share many of the same causes and triggers.
  • #55 Epidemiology of Asthma in Children and Adults
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6591438/
    There is considerable variation in the prevalence estimates of severe asthma. […] The proportion of severe asthmatics appears lower in childhood asthma compared to adult asthma. […] To provide a more useful clinical and research framework for the investigation of severe childhood asthma, Bush et al. have proposed the term Problematic severe asthma (PSA) for children who require specialist referral because of the apparent poor response to maximum asthma treatment. […] Although there is considerable within-group heterogeneity in each of the above categories, and strict differentiation may be challenging and on occasion not possible, the concepts which distinguish PSA, DA, and STRA are useful in both a research and clinical context. […] Childhood asthma and adult onset asthma are known to share many of the same causes and triggers.
  • #56 Asthma Surveillance – United States, 2006-2018 – PubMed
    https://pubmed.ncbi.nlm.nih.gov/34529643/
    Asthma is a chronic disease of the airways that requires ongoing medical management. Socioeconomic and demographic factors as well as health care use might influence health patterns in urban and rural areas. Characterizing asthma indicators (i.e., prevalence of current asthma, asthma attacks, emergency department and urgent care center [ED/UCC] visits, and asthma-associated deaths) and determining how asthma exacerbations and health care use vary across the United States by geographic area, including differences between urban and rural areas, and by sociodemographic factors can help identify subpopulations at risk for asthma-related complications. […] Current asthma was higher among boys aged 18 years, women aged 18 years, non-Hispanic Black (Black) persons, non-Hispanic multiple-race (multiple-race) persons, and Puerto Rican persons. Asthma attacks were more prevalent among children, females, and multiple-race persons. ED/UCC visits were more prevalent among children, women aged 18 years, and all racial and ethnic groups (i.e., Black, non-Hispanic Asian, multiple race, and Hispanic, including Puerto Rican, Mexican, and other Hispanic) except American Indian and Alaska Native persons compared with non-Hispanic White (White) persons. Asthma deaths were higher among adults, females, and Black persons. All pertinent asthma outcomes were also more prevalent among persons with low family incomes. Current asthma prevalence was higher in the Northeast than in the South and the West, particularly in small MSA areas. The prevalence was also higher in small and medium metropolitan areas than in large central metropolitan areas. The prevalence of asthma attacks differed by MSA category in four states. The prevalence of ED/UCC visits was higher in the South than the Northeast and the Midwest and was also higher in large central metropolitan areas than in micropolitan and noncore areas. The asthma mortality rate was highest in non-MSAs, specifically noncore areas. The asthma mortality rate was also higher in the Northeast, Midwest, and West than in the South. Within large MSAs, asthma deaths were higher in the Northeast and Midwest than the South and West.
  • #57 Asthma prevalence among United States population insights from NHANES data analysis | Scientific Reports
    https://www.nature.com/articles/s41598-024-58429-5
    Asthma is a prevalent long-term respiratory disease that impacts millions of people across all age groups in the US, with an approximate 89% prevalence rate. According to our estimated investigation, 8.7% of the population in the United States suffers from asthma. This percentage has varied in prior U. S publications, ranging from less than 3% to more than 20%. Asthma prevalence varies by nation and is impacted by a variety of variables, including genetics, environmental circumstances, healthcare infrastructure, and lifestyle. […] Our analysis reported high asthma prevalence among those with low income. Studies consistently demonstrate that asthma is more prevalent among individuals with lower household incomes. Factors like substandard housing, exposure to environmental pollutants, and limited access to healthcare can contribute to this disparity. Lower-income individuals often face disparities in healthcare access and quality, which can lead to inadequate management of asthma and increased prevalence. They may have limited access to preventative care, medications, and asthma education. Low-income communities are more likely to be exposed to environmental triggers for asthma, such as air pollution, allergens, and tobacco smoke. These exposures can exacerbate asthma symptoms and contribute to higher prevalence rates.
  • #58
    https://www.who.int/news-room/fact-sheets/detail/asthma
    The WHO Package of Essential Noncommunicable Disease Interventions (PEN) was developed to help improve NCD management in primary health care in low-resource settings. PEN includes protocols for the assessment, diagnosis and management of chronic respiratory diseases (asthma and chronic obstructive pulmonary disease), and modules on healthy lifestyle counselling, including tobacco cessation and self-care. […] Air pollution is an important risk factor for asthma, causing new cases and making existing disease worse.
  • #59 National Asthma and Allergy Awareness Month: Economic Costs, Threats to Access, and the Impact of Policy Changes
    https://www.ajmc.com/view/national-asthma-and-allergy-awareness-month-economic-costs-threats-to-access-and-the-impact-of-policy-changes
    Allergies and asthma affect millions in the US, with significant economic costs, especially for food allergies and asthma treatments. […] More than 28 million people in the US have received an asthma diagnosis, with the highest rates in Black adults. […] Asthma is considered one of the most common and costly diseases in the US, according to the AAFA. […] Reports indicate that the annual economic costs of asthma treatment are around $82 billion and medical costs make up almost $50.3 billion. […] Patients with allergies, asthma, or both experience substantial economic impacts and these challenges could impact access to necessary care and medications. The recent policy shifts regarding environmental regulations and public health infrastructure may have implications for the ongoing management and prevention of both allergy and asthma conditions.
  • #60 National Asthma and Allergy Awareness Month: Economic Costs, Threats to Access, and the Impact of Policy Changes
    https://www.ajmc.com/view/national-asthma-and-allergy-awareness-month-economic-costs-threats-to-access-and-the-impact-of-policy-changes
    Allergies and asthma affect millions in the US, with significant economic costs, especially for food allergies and asthma treatments. […] More than 28 million people in the US have received an asthma diagnosis, with the highest rates in Black adults. […] Asthma is considered one of the most common and costly diseases in the US, according to the AAFA. […] Reports indicate that the annual economic costs of asthma treatment are around $82 billion and medical costs make up almost $50.3 billion. […] Patients with allergies, asthma, or both experience substantial economic impacts and these challenges could impact access to necessary care and medications. The recent policy shifts regarding environmental regulations and public health infrastructure may have implications for the ongoing management and prevention of both allergy and asthma conditions.
  • #61 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    In addition, the costs of asthma hospitalizations are enormous—$763 million in 2005. This figure does not include the cost of ED visits, which are a precursor of asthma hospital admissions. Proper prevention efforts could reduce many of these poor outcomes and costs. […] In almost all measures of asthma burden, there are large disparities by race/ethnicity, income, age, gender, and geographic location. Blacks have especially disproportionate rates of ED visits, hospitalizations, and mortality. Although people of all incomes have a similar prevalence of asthma, people with lower incomes have more severe symptoms, higher rates of hospitalizations, and are more likely to have repeat hospitalizations.
  • #62 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    Over five million Californians have been diagnosed with asthma at some point in their lives, and almost three million currently have asthma. […] Using all of the most recent available surveillance data, this report presents a comprehensive summary of the burden of asthma in California. […] The majority of adults with asthma have mild symptoms, but about one in four have symptoms that are moderate or severe. About a third of children with asthma had an attack in the past year. […] Surveillance data show that there is much room for improvement in routine health care for people with asthma. Half of adults with asthma have not had a routine checkup for asthma in the past year and only about one-third of adults and children with asthma have received an asthma management plan. […] More encouraging is that the data indicate a decline in rates of the most severe outcomes—hospitalizations and deaths. Still, there are almost 500 deaths, 36,000 hospital discharges, and 145,000 emergency department (ED) visits (that did not result in hospitalization) per year due to asthma.
  • #63 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Asthma affects approximately 7% of the population of the United States and causes approximately 4,210 deaths per year. In 2005, asthma affected more than 22 million people, including 6 million children, and accounted for nearly 500,000 hospitalizations that same year. In 2010, asthma accounted for more than one-quarter of admitted emergency department visits in the U.S. among children aged 19 years, and it was a frequent diagnosis among children aged 10-17 years. From 2000 through 2010, the rate of pediatric hospital stays for asthma declined from 165 to 130 per 100,000 population, respectively, whereas the rate for adults remained about 119 per 100,000 population. […] Asthma prevalence in the U.S. is higher than in most other countries in the world, but varies drastically between ethnic populations. Asthma prevalence is highest in Puerto Ricans, Latino, African Americans, Filipinos, Irish Americans, and Native Hawaiians, and lowest in Mexicans and Koreans. Rates of asthma-related hospital admissions in 2010 were more than three times higher among African American children and two times higher for African American and Latino adults compared with White and Asian and Pacific Islander people. Also, children who are born in low-income families have higher risk of asthma.
  • #64 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Asthma affects approximately 7% of the population of the United States and causes approximately 4,210 deaths per year. In 2005, asthma affected more than 22 million people, including 6 million children, and accounted for nearly 500,000 hospitalizations that same year. In 2010, asthma accounted for more than one-quarter of admitted emergency department visits in the U.S. among children aged 19 years, and it was a frequent diagnosis among children aged 10-17 years. From 2000 through 2010, the rate of pediatric hospital stays for asthma declined from 165 to 130 per 100,000 population, respectively, whereas the rate for adults remained about 119 per 100,000 population. […] Asthma prevalence in the U.S. is higher than in most other countries in the world, but varies drastically between ethnic populations. Asthma prevalence is highest in Puerto Ricans, Latino, African Americans, Filipinos, Irish Americans, and Native Hawaiians, and lowest in Mexicans and Koreans. Rates of asthma-related hospital admissions in 2010 were more than three times higher among African American children and two times higher for African American and Latino adults compared with White and Asian and Pacific Islander people. Also, children who are born in low-income families have higher risk of asthma.
  • #65 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    Over five million Californians have been diagnosed with asthma at some point in their lives, and almost three million currently have asthma. […] Using all of the most recent available surveillance data, this report presents a comprehensive summary of the burden of asthma in California. […] The majority of adults with asthma have mild symptoms, but about one in four have symptoms that are moderate or severe. About a third of children with asthma had an attack in the past year. […] Surveillance data show that there is much room for improvement in routine health care for people with asthma. Half of adults with asthma have not had a routine checkup for asthma in the past year and only about one-third of adults and children with asthma have received an asthma management plan. […] More encouraging is that the data indicate a decline in rates of the most severe outcomes—hospitalizations and deaths. Still, there are almost 500 deaths, 36,000 hospital discharges, and 145,000 emergency department (ED) visits (that did not result in hospitalization) per year due to asthma.
  • #66 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    In addition, the costs of asthma hospitalizations are enormous—$763 million in 2005. This figure does not include the cost of ED visits, which are a precursor of asthma hospital admissions. Proper prevention efforts could reduce many of these poor outcomes and costs. […] In almost all measures of asthma burden, there are large disparities by race/ethnicity, income, age, gender, and geographic location. Blacks have especially disproportionate rates of ED visits, hospitalizations, and mortality. Although people of all incomes have a similar prevalence of asthma, people with lower incomes have more severe symptoms, higher rates of hospitalizations, and are more likely to have repeat hospitalizations.
  • #67 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    In addition, the costs of asthma hospitalizations are enormous—$763 million in 2005. This figure does not include the cost of ED visits, which are a precursor of asthma hospital admissions. Proper prevention efforts could reduce many of these poor outcomes and costs. […] In almost all measures of asthma burden, there are large disparities by race/ethnicity, income, age, gender, and geographic location. Blacks have especially disproportionate rates of ED visits, hospitalizations, and mortality. Although people of all incomes have a similar prevalence of asthma, people with lower incomes have more severe symptoms, higher rates of hospitalizations, and are more likely to have repeat hospitalizations.
  • #68 Epidemiology of asthma – Wikipedia
    https://en.wikipedia.org/wiki/Epidemiology_of_asthma
    Asthma affects approximately 7% of the population of the United States and causes approximately 4,210 deaths per year. In 2005, asthma affected more than 22 million people, including 6 million children, and accounted for nearly 500,000 hospitalizations that same year. In 2010, asthma accounted for more than one-quarter of admitted emergency department visits in the U.S. among children aged 19 years, and it was a frequent diagnosis among children aged 10-17 years. From 2000 through 2010, the rate of pediatric hospital stays for asthma declined from 165 to 130 per 100,000 population, respectively, whereas the rate for adults remained about 119 per 100,000 population. […] Asthma prevalence in the U.S. is higher than in most other countries in the world, but varies drastically between ethnic populations. Asthma prevalence is highest in Puerto Ricans, Latino, African Americans, Filipinos, Irish Americans, and Native Hawaiians, and lowest in Mexicans and Koreans. Rates of asthma-related hospital admissions in 2010 were more than three times higher among African American children and two times higher for African American and Latino adults compared with White and Asian and Pacific Islander people. Also, children who are born in low-income families have higher risk of asthma.
  • #69 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    In addition, the costs of asthma hospitalizations are enormous—$763 million in 2005. This figure does not include the cost of ED visits, which are a precursor of asthma hospital admissions. Proper prevention efforts could reduce many of these poor outcomes and costs. […] In almost all measures of asthma burden, there are large disparities by race/ethnicity, income, age, gender, and geographic location. Blacks have especially disproportionate rates of ED visits, hospitalizations, and mortality. Although people of all incomes have a similar prevalence of asthma, people with lower incomes have more severe symptoms, higher rates of hospitalizations, and are more likely to have repeat hospitalizations.
  • #70 Asthma Surveillance – United States, 2006-2018 – PubMed
    https://pubmed.ncbi.nlm.nih.gov/34529643/
    Asthma is a chronic disease of the airways that requires ongoing medical management. Socioeconomic and demographic factors as well as health care use might influence health patterns in urban and rural areas. Characterizing asthma indicators (i.e., prevalence of current asthma, asthma attacks, emergency department and urgent care center [ED/UCC] visits, and asthma-associated deaths) and determining how asthma exacerbations and health care use vary across the United States by geographic area, including differences between urban and rural areas, and by sociodemographic factors can help identify subpopulations at risk for asthma-related complications. […] Current asthma was higher among boys aged 18 years, women aged 18 years, non-Hispanic Black (Black) persons, non-Hispanic multiple-race (multiple-race) persons, and Puerto Rican persons. Asthma attacks were more prevalent among children, females, and multiple-race persons. ED/UCC visits were more prevalent among children, women aged 18 years, and all racial and ethnic groups (i.e., Black, non-Hispanic Asian, multiple race, and Hispanic, including Puerto Rican, Mexican, and other Hispanic) except American Indian and Alaska Native persons compared with non-Hispanic White (White) persons. Asthma deaths were higher among adults, females, and Black persons. All pertinent asthma outcomes were also more prevalent among persons with low family incomes. Current asthma prevalence was higher in the Northeast than in the South and the West, particularly in small MSA areas. The prevalence was also higher in small and medium metropolitan areas than in large central metropolitan areas. The prevalence of asthma attacks differed by MSA category in four states. The prevalence of ED/UCC visits was higher in the South than the Northeast and the Midwest and was also higher in large central metropolitan areas than in micropolitan and noncore areas. The asthma mortality rate was highest in non-MSAs, specifically noncore areas. The asthma mortality rate was also higher in the Northeast, Midwest, and West than in the South. Within large MSAs, asthma deaths were higher in the Northeast and Midwest than the South and West.
  • #71
    https://www.who.int/news-room/fact-sheets/detail/asthma
    Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children. […] Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths. […] Most asthma-related deaths occur in low- and lower-middle-income countries, where under-diagnosis and under-treatment is a challenge. […] Asthma is often under-diagnosed and under-treated, particularly in low- and middle-income countries. […] Access to inhalers is a problem in many countries. In 2021, bronchodilators were available in public primary health care facilities in half of low- and low-middle income countries, and steroid inhalers available in one third. […] Asthma is included in the WHO Global Action Plan for the Prevention and Control of NCDs and the United Nations 2030 Agenda for Sustainable Development.
  • #72
    https://www.who.int/news-room/fact-sheets/detail/asthma
    The WHO Package of Essential Noncommunicable Disease Interventions (PEN) was developed to help improve NCD management in primary health care in low-resource settings. PEN includes protocols for the assessment, diagnosis and management of chronic respiratory diseases (asthma and chronic obstructive pulmonary disease), and modules on healthy lifestyle counselling, including tobacco cessation and self-care. […] Air pollution is an important risk factor for asthma, causing new cases and making existing disease worse.
  • #73 Global Initiative for Asthma – Global Initiative for Asthma – GINA
    https://ginasthma.org/
    The GINA global strategy for asthma management and prevention is presented in its strategy documents, which are freely available on the GINA Website. […] We work with health care professionals, patient representatives, and public health officials around the world to reduce asthma prevalence, morbidity, and mortality. […] GINA emphasizes the need to ensure that people with asthma can access inhaled medications that are essential both for controlling the underlying disease and treating attacks. […] Asthma attacks cause great distress for sufferers and their carers, and these attacks may result in hospital admission and, in some cases, death.
  • #74 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    The key barriers to effective KT for asthma using EMR data are lack of documentation of confirmation of an asthma diagnosis, challenges related to creating a valid EMR case definition for asthma in the absence of this documentation, and the limitations of data sources that can inform KT eTools. […] Existing KT tools for asthma have been limited in scope and many fail to address barriers and challenges in primary care, where the majority of asthma diagnoses are made.
  • #75 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    Future initiatives in the development of KT eTools for asthma care should focus on strategies that assist healthcare providers in accurately diagnosing and documenting cases of asthma. […] A digital asthma surveillance system could support adherence to best-practice guidelines of asthma diagnosis and surveillance by prompting use of objective methods of confirmation to confirm an asthma diagnosis within the EMR. […] Globally, the number of people diagnosed with asthma is over 340 million and has continually increased over a 10-year period. […] A major contributor to the burden of asthma on individuals and the healthcare system is that gaps exist between the published guidelines for asthma diagnosis and actual strategies for diagnosis used in primary care. […] Although standards for asthma diagnosis are well established, less than half of individuals diagnosed with asthma have a confirmed diagnosis through the use of objective measurements of pulmonary function within two years of their original diagnosis.
  • #76 Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement | Allergy, Asthma & Clinical Immunology | Full Text
    https://aacijournal.biomedcentral.com/articles/10.1186/s13223-022-00755-2
    The key barriers to effective KT for asthma using EMR data are lack of documentation of confirmation of an asthma diagnosis, challenges related to creating a valid EMR case definition for asthma in the absence of this documentation, and the limitations of data sources that can inform KT eTools. […] Existing KT tools for asthma have been limited in scope and many fail to address barriers and challenges in primary care, where the majority of asthma diagnoses are made.
  • #77 Can a single pollen measurement site provide exposure information for health research across an entire state? Results from a study of allergic-type asthma associated with thunderstorms (2007–2018) | Journal of Exposure Science & Environmental Epidemio
    https://www.nature.com/articles/s41370-025-00777-z
    Thunderstorm asthma is an increase in severe asthma following thunderstorm events during high pollen conditions. However, sparse pollen measurements hinder epidemiological research of this phenomenon. […] Investigating thunderstorm asthma in the U.S. is challenged by sparse measurement of pollen data, with fewer than 60 stations available nationwide. […] The phenomenon of thunderstorm asthma in the U.S. remains poorly studied due to geographically sparse pollen collection sites. […] Our findings suggest that locations with plants similar to a remote pollen measurement location may have comparable daily pollen loads and provide predictive value for thunderstorm asthma research. […] Our research suggests additional pollen measurements might allow for more accurate thunderstorm asthma prediction, and previous work suggests that a greater density of pollen measurements is required. […] This study highlights the importance of additional pollen measurement in the United States for further research into this specific health outcome and other important research areas, including studies of allergenic response and the spatiotemporal spread of pollen.
  • #78 Asthma Surveillance – United States, 2006-2018 – PubMed
    https://pubmed.ncbi.nlm.nih.gov/34529643/
    Despite some improvements in asthma outcomes over time, the findings from this report indicate that disparities in asthma indicators persist by demographic characteristics, poverty level, and geographic location. […] Disparities in asthma outcomes and health care use in rural and urban populations identified from NHIS and NVSS can aid public health programs in directing resources and interventions to improve asthma outcomes.
  • #79 Asthma Surveillance – United States, 2006-2018 – PubMed
    https://pubmed.ncbi.nlm.nih.gov/34529643/
    Despite some improvements in asthma outcomes over time, the findings from this report indicate that disparities in asthma indicators persist by demographic characteristics, poverty level, and geographic location. […] Disparities in asthma outcomes and health care use in rural and urban populations identified from NHIS and NVSS can aid public health programs in directing resources and interventions to improve asthma outcomes.
  • #80 Asthma prevalence among United States population insights from NHANES data analysis | Scientific Reports
    https://www.nature.com/articles/s41598-024-58429-5
    Asthma is a prevalent respiratory condition that poses a substantial burden on public health in the United States. Understanding its prevalence and associated risk factors is vital for informed policymaking and public health interventions. This study aims to examine asthma prevalence and identify major risk factors in the U.S. population. Our study utilized NHANES data between 1999 and 2020 to investigate asthma prevalence and associated risk factors within the U.S. population. The study found that asthma affected 8.7% of the U.S. population. Gender emerged as a significant factor, with 36.0% of asthma patients being male and 64.0% female (p0.001). Individuals aged 60 and older having the highest asthma prevalence at 34.0%. Non-Hispanic whites had the highest prevalence at 46.4%, followed by non-hispanic blacks at 26.0%. In contrast, Mexican Americans and other hispanic individuals had lower rates, at 9.6% and 9.0%, respectively. Females were 1.76 times more likely to have asthma than males (p0.001). Obese individuals had a 1.74 times higher likelihood of current asthma compared to underweight individuals (p0.001). Notably, both Non-Hispanic Whites and Non-Hispanic Blacks showed higher odds of current asthma compared to Mexican Americans (with adjusted odds ratios of 2.084 and 2.096, respectively, p0.001). The research findings indicate that asthma is prevalent in 8.7% of the U.S. population. Our study highlights that individuals who are female, have low income, are obese, and smoke have the highest likelihood of being affected by asthma. Therefore, public health policies should prioritize addressing these risk factors in their preventive strategies.
  • #81 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    Over five million Californians have been diagnosed with asthma at some point in their lives, and almost three million currently have asthma. […] Using all of the most recent available surveillance data, this report presents a comprehensive summary of the burden of asthma in California. […] The majority of adults with asthma have mild symptoms, but about one in four have symptoms that are moderate or severe. About a third of children with asthma had an attack in the past year. […] Surveillance data show that there is much room for improvement in routine health care for people with asthma. Half of adults with asthma have not had a routine checkup for asthma in the past year and only about one-third of adults and children with asthma have received an asthma management plan. […] More encouraging is that the data indicate a decline in rates of the most severe outcomes—hospitalizations and deaths. Still, there are almost 500 deaths, 36,000 hospital discharges, and 145,000 emergency department (ED) visits (that did not result in hospitalization) per year due to asthma.
  • #82 The Burden of Asthma in California: A Surveillance Report – Public Health Institute
    https://www.phi.org/thought-leadership/the-burden-of-asthma-in-california-a-surveillance-report/
    Over five million Californians have been diagnosed with asthma at some point in their lives, and almost three million currently have asthma. […] Using all of the most recent available surveillance data, this report presents a comprehensive summary of the burden of asthma in California. […] The majority of adults with asthma have mild symptoms, but about one in four have symptoms that are moderate or severe. About a third of children with asthma had an attack in the past year. […] Surveillance data show that there is much room for improvement in routine health care for people with asthma. Half of adults with asthma have not had a routine checkup for asthma in the past year and only about one-third of adults and children with asthma have received an asthma management plan. […] More encouraging is that the data indicate a decline in rates of the most severe outcomes—hospitalizations and deaths. Still, there are almost 500 deaths, 36,000 hospital discharges, and 145,000 emergency department (ED) visits (that did not result in hospitalization) per year due to asthma.